[en] Ketoconazole (KET) is active to control dandruff and seborrhoeic dermatitis. Objective assessments comparing the 1% and 2% shampoo formulations are scant. This open, randomized parallel-group trial was carried out to differentiate the effectiveness of KET 1% and 2% in severe dandruff and seborrhoeic dermatitis. A total of 66 patients with severe dandruff or seborrhoeic dermatitis were randomized to each of the two groups. A 2-week run-in phase was followed by a 4-week treatment phase, in turn followed by a 4-week follow-up. The efficacy of treatments was evaluated by combining squamometry X, Malassezia spp. counts and clinical assessments. After 2 and 4 weeks of treatment, KET 2% was significantly superior over KET 1% (p < 0.001) for decreasing both in flakiness and Malassezia density from baseline. The same trend was observed in the mean change from baseline in the overall dandruff severity score. Only 6 mild adverse events were reported. During follow-up KET 2% showed a trend to fewer relapses than KET 1%. KET 2% had superior efficacy compared to KET 1% in the treatment of severe dandruff and scalp seborrhoeic dermatitis. Biometrological evaluations were correlated with the clinical improvements and therefore useful to incorporate in future dandruff studies.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Shuster, S., The aetiology of dandruff and the mode of action of therapeutic agents (1984) Br J Dermatol, 111, pp. 235-242
Faergemann, J., Management of seborrheic dermatitis and pityriasis versicolor (2000) Am J Clin Dermatol, 1, pp. 75-80
Piérard-Franchimont, C., Hermanns, J.F., Degreef, H., Piérard, G.E., From axioms to new insights into dandruff (2000) Dermatology, 200, pp. 93-98
Piérard-Franchimont, C., Willemaers, V., Fraiture, A.L., Piérard, G.E., Squamometry in seborrheic dermatitis (1999) Int J Dermatol, 38, pp. 712-715
Faergemann, J., Propylene glycol in the treatment of seborrheic dermatitis of the scalp: A double-blind study (1988) Cutis, 42, pp. 69-71
Ford, G.P., Farr, P.M., Ive, F.A., Shuster, S., The response of seborrhoeic dermatitis to ketoconazole (1984) Br J Dermatol, 111, pp. 603-607
Skinner, R.B., Noah, P.W., Taylor, R.M., Zanolli, M.D., West, S., Gwin, J.D., Rosenberg, E.W., Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream (1985) J Am Acad Dermatol, 2, pp. 852-857
Cauwenbergh, G., De Doncker, P., Schrooten, P., Degreef, H., Treatment of dandruff with a 2% ketoconazole scalp gel: A double-blind, placebo-controlled study (1986) Int J Dermatol, 25, p. 541
Berger, R., Mills, O.H., Johnson, R.W., Jones, E.L., Mrusck, S., Double-blind, placebo-controlled trial of ketoconazole 2% shampoo in the treatment of moderate to severe dandruff (1990) Adv Ther, 7, pp. 247-256
Faergemann, J., Treatment of seborrhoeic dermatitis of the scalp with ketoconazole shampoo (1990) Acta Derm Venereol, 70, pp. 171-172
Danby, F.W., Maddin, W.S., Margesson, L.J., Rosenthal, D., A randomised double-blind study of ketoconazole 2% shampoo versus selenium sulphide 2.5% shampoo in the treatment of moderate to severe dandruff (1993) J Am Acad Dermatol, 29, pp. 1008-1012
Shuttleworth, D., Squire, R.A., Boorman, G.C., Goode, K., Comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) or ketoconazole (2%
Nizoral) for the control of dandruff/seborrhoeic dermatitis (1998) J Dermatol Treat, 9, pp. 157-162
Stratigos, I.D., Antoniou, C.H., Katambas, A., Böhler, K., Fritsch, P., Schmölz, A., Michaelidis, D., De Beule, K., Ketoconazole 2% cream versus 1% hydrocortisone cream in the treatment of seborrheic dermatitis: A double-blind comparative study (1988) J Am Acad Dermatol, 19, pp. 850-853
Ortonne, J.P., Lacour, J.P., Vitetta, A., Le Fichoux, Y., Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults (1992) Dermatology, 184, pp. 275-280
Pari, T., Pulimood, S., Jacob, M., George, S., Jeyaseehan, L., Thomas, K., Randomised double-blind controlled trial of 2% ketoconazole cream versus 0.05% clobetasol 17-butyrate cream in seborrhoeic dermatitis (1998) J Eur Acad Dermatol Venereol, 10, pp. 89-90
Vanit Veen, A.J., Prevoo, R.L.M.A., Velders, A.J., Jagtman, B.A., Van Niel, J.C.G., Stolz, E., Betamethasone-17-valerate compared with ketoconazole for topical treatment of seborrhoeic dermatitis of the scalp in adults: Results of a Dutch multicentre study (1998) J Dermatol Treat, 9, pp. 239-245
Piérard-Franchimont, C., Arrese, J.E., Durupt, G., Ries, G., Cauwenbergh, G., Piérard, G.E., Correlation between Malassezia spp. load and dandruff severity (1998) J Mycol Med, 8, pp. 83-86
Piérard, G.E., EEMCO guidance for the assessment of dry skin (xerosis) and ichthyosis: Evaluation by stratum corneum strippings (1996) Skin Res Technol, 2, pp. 3-11
Arrese, J.E., Piérard-Franchimont, C., De Doncker, P., Heremans, A., Cauwenbergh, G., Piérard, G., Effect of ketoconazole-medicated shampoos on squamometry and Malassezia ovalis load in pityriasis capitis (1996) Cutis, 58, pp. 235-237
Piérard-Franchimont, C., De Doncker, P., Wallace, R., Cauwenbergh, G., Piérard, G.E., Ketoconazole shampoo: Effect of long-term use in androgenic alopecia (1998) Dermatology, 196, pp. 474-477
Piérard-Franchimont, C., Henry, F., Piérard, G.E., The SACD method and the XLRS squamometry tests revisited (2000) Int J Cosmet Sci, 22, pp. 437-446
Piérard, G.E., EEMCO guidance for the assessment of skin colour (1998) J Eur Acad Dermatol Venereol, 10, pp. 1-11
Piérard-Franchimont, C., Arrese, J.E., Piérard, G.E., Immunohistochemical aspects of the link between Malassezia ovalis and seborrhoeic dermatitis (1995) J Eur Acad Dermatol Venereol, 4, pp. 14-19
Kesavan, S., Walters, C.E., Holland, K.T., Ingham, E., The effects of Malassezia on proinflammatory cytokine production by human peripheral blood mononuclear cells in vitro (1998) Med Mycol, 36, pp. 97-106
Pearry, M.E., Sharpe, G.R., Seborrhoeic dermatitis is not caused by an altered immunoresponse to Malassezia yeast (1998) Br J Dermatol, 139, pp. 254-263
Bergbrant, I.-M., Andersson, B., Faergemann, J., Cell-mediated immunity to Pityrosporum ovale in patients with seborrhoeic dermatitis and pityriais versicolor (1999) Clin Exp Dermatol, 24, pp. 402-406
Janssen, P.A., Van den Bossche, H., Van Wauwe, J.P., Cauwenbergh, G.F., Degreef, H.J., The role of cytochrome P-450 in dermatology (1989) Int J Dermatol, 28, pp. 493-496
Baroni, A., Ruocco, V., De Paolis, P., Cicatiello, L., Esumi, Tufano, M.A., Ketoconazole inhibits lipopolysaccharide-induced activation of the nitric oxide synthase gene in the murine macrophage cell line J774 (1999) Arch Dermatol Res, 291, pp. 54-58
Van Cutsem, J., Van Gerven, F., Cauwenbergh, G., Odds, F., Janssen, P.A.J., The anti-inflammatory effects of ketoconazole (1991) J Am Acad Dermatol, 25, pp. 257-261
Rico, A.C., Lopez, G.H., Munoz, L.H., Bejarano, C.V., Evaluation del efecto antiinflamatorio de ketoconazole cream (1991) Invest Med Int, 18, pp. 181-187
Yoshimura, T., Kudoh, K., Aiba, S., Tagami, H., Anti-inflammatory effects of ketoconazole for the inflammation induced on the skin of hairless guinea-pigs by repeated applications of heat-killed spores of M. furfur: A comparative study with hydrocortisone 17-butyrate (1995) J Dermatol Treat, 6, pp. 113-116
Roosen, T., Schell, B.J., Orengo, I., Anti-inflammatory activity of antifungal preparations (1997) Int J Dermatol, 36, pp. 788-792
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
